LabCorp launches Qiagen's colon cancer companion Dx; Hospitals pursue med device testing partnership;

@FierceMedDev: Myriad slaps Quest with BRCA cancer test patent suit. Article | Follow @FierceMedDev

@MarkHFierce: Stryker paid $13.2M to settle SEC bribery charges but doesn't admit or deny any wrongdoing. Story | Follow @MarkHFierce

@MichaelGFierce: This week's Chutes & Ladders from FierceBiotech: Eli Lilly's board elects multinational financial leader, and more. Item | Follow @MichaelGFierce

> LabCorp ($LH) will start selling Qiagen's new companion diagnostic for colorectal cancer patients, which is designed to spot patients best suited for Eli Lilly's ($LLY) Erbitux drug treatment. Item

> ACell, a Maryland company developing surgical and wound-management products, has begun expanding its manufacturing facility in Lafayette, IN. Item

> Henry Ford Hospital in Detroit and Windsor Regional Hospital in Ontario, Canada, are developing plans to join forces on medical device research and testing. Story

> Danish device company R82 A/S faces an FDA warning letter addressing quality system violations in products such as its Cougar, Panther and Cheetah wheelchairs, as well as its Rabbit-brand mobile standing frame. Letter

> Beckman Coulter obtained a CE mark for a new, enhanced vitamin D assay. Item

> Are cardiac stents overused? An essay in The New Yorker explores the issue. Blog

Biotech News

@FierceBiotech: J&J wins FDA panel blessing for hepatitis C blockbuster hopeful. Story | Follow @FierceBiotech

@JohnCFierce: Let's see. Friday. Today Gilead's team will take its bows at the sofosbuvir panel. Then a vote and break for celebratory drinks, pictures. | Follow @JohnCFierce

@DamianFierce: Aerie prices $67M IPO and becomes 40th biotech to go public this year. More | Follow @DamianFierce

@EmilyMFierce: When is a medical treatment unnecessary? Article | Follow @EmilyMFierce

> Public Citizen goes on a witch hunt at the FDA. Editor's corner

> Versant Ventures amassing $200M fund for biotech upstarts. More

> Alexion bags another FDA 'breakthrough' for rare-disease drug. Story

Pharma News

@FiercePharma: ICYMI: GSK saves $431M moving retirees to private healthcare exchanges. Story | Follow @FiercePharma

@EricPFierce: South Africa's Aspen Pharmacare is a major generic drugmaker poised to get bigger. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI: With Aptalis sale a no-go, TPG plots IPO instead. More | Follow @CarlyHFierce

> Celgene raises earnings forecast third time. More

> FDA again finds itself playing role as pain med police. Story

> Japan's frustrated Eisai loses fight with DEA. Article

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.